Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.
Int J Clin Pharm
; 43(4): 1139-1148, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1293413
ABSTRACT
One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise the public health benefit of available vaccines, there is a pressing need to vaccinate a large proportion of the population. Internationally, this has prompted coordination of existing services at enormous scale, and development and implementation of novel vaccination strategies to ensure maximum inoculation over the shortest possible timeframe. Pharmacists are being promoted as healthcare professionals that enhance roll-out of COVID-19 vaccination programmes. This paper aims to summarise current policy and practice in relation to pharmacists' involvement in COVID-19 vaccination in 13 countries across Europe.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pharmacists
/
Professional Role
/
COVID-19 Vaccines
/
Health Policy
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Int J Clin Pharm
Year:
2021
Document Type:
Article
Affiliation country:
S11096-021-01301-7
Similar
MEDLINE
...
LILACS
LIS